Search

Your search keyword '"Bernabei, Roberto"' showing total 122 results

Search Constraints

Start Over You searched for: Author "Bernabei, Roberto" Remove constraint Author: "Bernabei, Roberto" Topic sarcopenia Remove constraint Topic: sarcopenia
122 results on '"Bernabei, Roberto"'

Search Results

1. Effects of a 2-year exercise training on neuromuscular system health in older individuals with low muscle function.

2. Determinants of cardiac structure in frail and sarcopenic elderly adults.

3. Identification of biomarkers for physical frailty and sarcopenia through a new multi-marker approach: results from the BIOSPHERE study.

4. Biomarkers of Physical Frailty and Sarcopenia: Coming up to the Place?

5. Older Adults with Physical Frailty and Sarcopenia Show Increased Levels of Circulating Small Extracellular Vesicles with a Specific Mitochondrial Signature.

6. Gut Microbial, Inflammatory and Metabolic Signatures in Older People with Physical Frailty and Sarcopenia: Results from the BIOSPHERE Study.

7. Inflammatory signatures in older persons with physical frailty and sarcopenia: The frailty "cytokinome" at its core.

8. Assessment of Muscle Function and Physical Performance in Daily Clinical Practice : A position paper endorsed by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).

9. Sarcopenia-related parameters in adults with Down syndrome: A cross-sectional exploratory study.

10. Targeting mitochondrial quality control for treating sarcopenia: lessons from physical exercise.

11. A Distinct Pattern of Circulating Amino Acids Characterizes Older Persons with Physical Frailty and Sarcopenia: Results from the BIOSPHERE Study.

12. The "Sarcopenia and Physical fRailty IN older people: multi-componenT Treatment strategies" (SPRINTT) randomized controlled trial: Case finding, screening and characteristics of eligible participants.

13. The "BIOmarkers associated with Sarcopenia and PHysical frailty in EldeRly pErsons" (BIOSPHERE) study: Rationale, design and methods.

14. Circulating Mitochondrial DNA at the Crossroads of Mitochondrial Dysfunction and Inflammation During Aging and Muscle Wasting Disorders.

15. A review of telomere length in sarcopenia and frailty.

16. Sarcopenia in Parkinson Disease: Comparison of Different Criteria and Association With Disease Severity.

17. Update on mitochondria and muscle aging: all wrong roads lead to sarcopenia.

18. Gut Dysbiosis and Muscle Aging: Searching for Novel Targets against Sarcopenia.

19. Biomarkers for Sarcopenia: Reductionism vs. Complexity.

20. Mitochondrial dynamics signaling is shifted toward fusion in muscles of very old hip-fractured patients: Results from the Sarcopenia in HIp FracTure (SHIFT) exploratory study.

21. Measurement of muscle mass in sarcopenia: from imaging to biochemical markers.

22. Rationale for a preliminary operational definition of physical frailty and sarcopenia in the SPRINTT trial.

23. Sarcopenia: an overview.

24. Biomarkers for physical frailty and sarcopenia.

25. The "Sarcopenia and Physical fRailty IN older people: multi-componenT Treatment strategies" (SPRINTT) randomized controlled trial: design and methods.

26. Physical activity and exercise as countermeasures to physical frailty and sarcopenia.

27. Impact of physical function impairment and multimorbidity on mortality among community-living older persons with sarcopaenia: results from the ilSIRENTE prospective cohort study.

28. Association between myocyte quality control signaling and sarcopenia in old hip-fractured patients: Results from the Sarcopenia in HIp FracTure (SHIFT) exploratory study.

29. Serum levels of C-terminal agrin fragment (CAF) are associated with sarcopenia in older multimorbid community-dwellers: Results from the ilSIRENTE study.

30. Sarcopenia as the Biological Substrate of Physical Frailty.

31. Serum levels of C-terminal agrin fragment (CAF) are associated with sarcopenia in older hip fractured patients.

32. Association of sarcopenia with short- and long-term mortality in older adults admitted to acute care wards: results from the CRIME study.

33. Exercise as a remedy for sarcopenia.

34. Frailty, Physical Frailty, Sarcopenia: A New Conceptual Model.

35. Sarcopenia and diabetes: two sides of the same coin.

36. Nonsteroidal anti-inflammatory drug (NSAID) use and sarcopenia in older people: results from the ilSIRENTE study.

37. Association of anorexia with sarcopenia in a community-dwelling elderly population: results from the ilSIRENTE study.

38. Mitochondrial pathways in sarcopenia of aging and disuse muscle atrophy.

39. Sarcopenia and mortality risk in frail older persons aged 80 years and older: results from ilSIRENTE study.

40. Sarcopenia as a risk factor for falls in elderly individuals: results from the ilSIRENTE study.

41. Commentaries on Viewpoint: Muscle atrophy is not always sarcopenia.

42. Sarcopenia and mortality among older nursing home residents.

43. Prevalence and risk factors of sarcopenia among nursing home older residents.

44. Apoptosis in skeletal myocytes: a potential target for interventions against sarcopenia and physical frailty - a mini-review.

45. Effects of treadmill exercise and training frequency on anabolic signaling pathways in the skeletal muscle of aged rats.

46. Midarm muscle circumference, physical performance and mortality: results from the aging and longevity study in the Sirente geographic area (ilSIRENTE study).

47. Mitochondrial death effectors: relevance to sarcopenia and disuse muscle atrophy.

48. Muscle wasting disease: a proposal for a new disease classification.

49. Falls among Older Adults: Screening, Identification, Rehabilitation, and Management.

Catalog

Books, media, physical & digital resources